-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBRX ANNOUNCES U.S. FDA ACCEPTANCE OF BLA FOR OZEKIBART IN PATIENTS WITH CONVENTIONAL CHONDROSARCOMA

Reuters·06/15/2026 13:15:00

Please log in to view news